Free AI-powered tools

Free AI-powered tools for pharmaceutical GMP professionals

Six AI-powered tools built from 27 years of pharmaceutical GMP training experience and current FDA enforcement data. Free to try. No login required.

6
Tools available now
Free
No login required
27 yrs
Training experience
More
Tools coming soon
1
Training Assessment

Find your GMP training priorities

Not sure where to start in the GMPify catalog? Answer 10 questions about your role, site type, regulatory markets and inspection timeline. Get back a personalised list of the 5 courses you need most - in order - with a specific explanation of why each one matters for your exact situation.

Role-specific recommendations - QA, QC, validation, microbiology, regulatory affairs and more
Inspection timeline aware - courses prioritised differently for sites with imminent inspections
Specific reasoning for each course - not a generic list, a plan built around your answers
Direct subscribe link on results page - go from assessment to training in one step
10 questions 2 minutes 5 priority courses Personalised Free
Start the assessment →
How it works
1
Answer 10 questions about your role, site, markets and inspection situation
2
Claude analyses your profile against current FDA and EU GMP enforcement data
3
Receive your personalised 5-course priority list with specific explanations
4
Subscribe and start your first priority course immediately
Who this is for
Anyone new to GMPify or looking to identify their highest-priority training gaps. Particularly useful for professionals preparing for an FDA or EU GMP inspection.
2
Regulation Explainer

Explain any GMP regulation instantly

Paste any pharmaceutical regulation reference and get back an expert plain-language explanation in seconds. No searching through 40 pages of guidance. No ambiguity about what it means in practice. Built from 27 years of pharmaceutical GMP training experience and current FDA 483 observation and warning letter data.

Covers 21 CFR Parts 210 and 211, EU GMP Annex 1, all ICH guidelines and USP chapters
What it says, what it means in practice, what inspectors look for and the most common violation
Related regulations listed so you can explore connected requirements
Current FDA enforcement data - reflects FY2024 and 2025 inspection priorities
21 CFR EU GMP USP chapters ICH guidelines Instant Free
Try the Regulation Explainer →
Example queries
?
21 CFR 211.192 - deviation investigation requirements
?
EU GMP Annex 1 Section 4.3 - RABS and isolator requirements
?
USP 85 method suitability - what is required
?
ICH Q9(R1) - what changed in the 2023 revision
Who this is for
Any pharmaceutical professional who needs to quickly understand what a regulation requires, what inspectors look for and where sites most commonly fail.
3
483 Response Drafter

Draft a compliant 483 response in minutes

Enter your observation details and get a fully structured draft response built from the March 2026 FDA draft guidance - the first document FDA has published consolidating its 483 response content requirements. All six required sections, ready to adapt and submit within your 15-business-day deadline.

All six required sections per the March 2026 guidance - executive summary, patient risk assessment, investigation report, CAPA plan, effectiveness evaluation and administrative elements
Bias-aware root cause analysis framework built in - meets the March 2026 guidance requirement
Effectiveness check criteria that go beyond routine testing - as required by the March 2026 guidance
Copy all button - paste the entire structured draft into Word immediately
Placeholder checklist - every item you need to complete before submitting
March 2026 FDA guidance 6 required sections 15-day deadline Copy to Word Free
Draft my 483 response →
What you need to start
1
Your site name and FEI number
2
The exact observation text from your Form 483
3
Your product type and CFR section cited
4
Any immediate actions already taken (optional)
Who this is for
QA managers, regulatory affairs professionals and site directors who need to draft or review a 483 response quickly and ensure it meets current FDA expectations.
4
SOP Gap Analyser

Find the gaps in your SOP before FDA does

Upload your SOP or paste its text. Select the regulatory standard to analyse against. Get a structured gap analysis identifying what is missing, what language FDA has cited as inadequate and specific recommended additions - across 20 regulatory standards including 21 CFR, EU GMP Annex 1, FDA guidance documents and ICH guidelines.

Covers 20 regulatory standards - 21 CFR sections, EU GMP chapters and annexes, FDA guidance documents, ICH guidelines and USP chapters
Each gap rated Critical, Major, Minor or Observation with the specific regulatory basis and the FDA enforcement pattern from real 483 and warning letter data
Specific recommended language for each gap - not generic advice but actual suggested SOP content to add
Upload PDF or Word files, or paste text directly - full document analysis in under 30 seconds
Copy full report button - export the complete gap analysis as plain text for use in your quality system
21 CFR and EU GMP PDF and Word upload FDA enforcement data Specific recommendations Free
Analyse my SOP →
How it works
1
Select the regulatory standard to analyse against from 20 options
2
Upload your SOP as a PDF or Word file, or paste the text directly
3
Receive a gap analysis with each finding prioritised and linked to the specific regulation
4
Use the specific recommended language to update your SOP
Who this is for
QA managers preparing for inspections, quality professionals reviewing existing SOPs, and anyone who wants to verify their procedures meet current FDA and EU GMP expectations before an investigator does.
5
Deviation Investigation Framework Builder

Build a complete investigation framework in under a minute

Describe your manufacturing deviation and get a complete six-section investigation framework - scope determination, root cause methodology, CAPA structure, effectiveness criteria, documentation requirements and regulatory notification assessment. Directly addresses the number one FDA 483 citation pattern under 21 CFR 211.192 - failure to thoroughly investigate unexplained discrepancies.

Covers 30 deviation categories across manufacturing, laboratory, documentation, materials and sterile manufacturing - including media fill failures, OOS results, environmental monitoring exceedances and process parameter deviations
Six-section framework including scope determination, root cause analysis methodology with specific categories based on FDA enforcement data, CAPA implementation timeline and effectiveness check criteria
Identifies the most common FDA finding for your specific deviation type - what investigators cite as inadequate root cause analysis and what CAPA approaches FDA consistently rejects
Regulatory notification assessment covering FDA and EU GMP escalation criteria, recall triggers and how to present the investigation to an inspector
Copy full framework button - exports all six sections as plain text for use directly in your quality system
21 CFR 211.192 Root cause analysis CAPA structure FDA enforcement data Free
Build my investigation framework →
Six framework sections
1
Scope determination and immediate actions - what to do in the first 24 hours
2
Root cause analysis methodology - recommended approach and data to gather
3
CAPA structure - corrective and preventive actions with 90-day implementation timeline
4
Effectiveness check criteria - specific measurable metrics and monitoring period
5
Documentation requirements - investigation report structure and Quality Unit responsibilities
6
Regulatory notifications - escalation criteria, recall triggers and inspection readiness
Who this is for
QA managers, quality professionals and site directors who need to initiate a deviation investigation quickly, ensure it meets current FDA and EU GMP requirements and avoid the investigation failures that generate 483 observations.
6
Environmental Monitoring Programme Reviewer
New

Review your EM programme against EU GMP Annex 1 2022

Describe your environmental monitoring programme - facility type, cleanroom grades, monitoring methods, how alert and action limits are set, your CCS status and recent excursion history. Get a structured gap analysis identifying what inspectors will find before they arrive.

Gap analysis against EU GMP Annex 1 2022 Sections 4 and 9 and FDA aseptic processing guidance - with current 2025 and 2026 inspection finding patterns for each gap identified.
Separate assessment cards for alert and action limit methodology, trending programme adequacy and excursion management - the three areas inspectors assess most thoroughly in every EM review.
CCS integration assessment - evaluating whether your EM programme is connected to your Contamination Control Strategy as required under Annex 1 2022.
Priority action list for before your next inspection. Copy the full report to Word with one click.
Review my EM programme →
Coming soon

More tools coming soon

New tools added regularly as GMPify grows. Subscribe to be notified when each one launches.

🧪
Environmental Monitoring Programme Reviewer
Describe your EM programme parameters and get a gap analysis against EU GMP Annex 1 2022 and FDA inspection expectations - identifying alert and action limit adequacy, sampling location rationale and trending requirements.
In development
🔍
Inspection Readiness Checker
Answer questions about your quality system and get a prioritised risk report identifying your highest-probability 483 findings - with specific recommended actions to take before the investigator arrives.
In development

Get full access to GMPify courses

All tools are free to use. For the full catalog of on-demand pharmaceutical GMP courses with certificates, subscribe from $69 per month.

Subscribe - from $69/month
Full catalog access from day one. Certificate on every course. Cancel anytime.